Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINHALATIONStandard

FLOVENT DISKUS 250

FLUTICASONE PROPIONATE

Standard Dose
0.25MG/INH
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview FLOVENT DISKUS 250 is listed in Drugs@FDA under application 020833 (NDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient FLUTICASONE PROPIONATE Form and strength POWDER;INHALATION - 0.25MG/INH Sponsor GLAXO GRP LTD Submission history Latest submission status date: 2019-01-07 00:00:00.

Structured Monograph

Clinical summary

Approval overview FLOVENT DISKUS 250 is listed in Drugs@FDA under application 020833 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient FLUTICASONE PROPIONATE Form and strength POWDER;INHALATION - 0.25MG/INH Sponsor GLAXO GRP LTD Submission history Latest submission status date: 2019-01-07 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.